Literature DB >> 25065412

Detecting objective and subjective cognitive effects of electroconvulsive therapy: intensity, duration and test utility in a large clinical sample.

G Fernie1, D M Bennett1, J Currie1, J S Perrin1, I C Reid1.   

Abstract

BACKGROUND: Electroconvulsive therapy (ECT) is an effective treatment for depression but the extent and persistence of cognitive side-effects remain uncertain. It has been reported that there is little evidence that impairments last longer than up to 15 days post-ECT. However, relatively few studies have followed patients for even as long as 1 month post-ECT. Here we report results from a brief cognitive battery given prior to ECT and repeated five times up to 6 months post-ECT.
METHOD: In a retrospective case-note study of routinely collected clinical data 126 patients treated with ECT completed two neuropsychological tests [Cambridge Neuropsychological Test Automated Battery (CANTAB) spatial recognition memory (SRM) and Mini Mental State Examination (MMSE)] and two subjective reports of memory function, prior to ECT. Patients were reassessed following ECT and at 1, 3 and 6 months post-ECT although not all patients completed all assessments.
RESULTS: Performance relative to pre-ECT baseline was significantly poorer at each post-ECT assessment up to 3 months post-ECT using the CANTAB SRM, but was improved at 6 months. Conversely, MMSE score showed improvements relative to baseline from 1 month post-ECT. Mood and subjective memory scores improved following ECT and were correlated with one another, but not with either neuropsychological measure.
CONCLUSIONS: The CANTAB SRM task revealed reversible cognitive deficiencies relative to a pre-ECT baseline for at least 3 months following ECT, while MMSE score and patients' subjective reports showed only improvement. Visuospatial memory scores eventually exceeded baseline 6 months post-ECT.

Entities:  

Mesh:

Year:  2014        PMID: 25065412     DOI: 10.1017/S0033291714000658

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  15 in total

1.  Short- and Long-term Cognitive Outcomes in Patients With Major Depression Treated With Electroconvulsive Therapy.

Authors:  Megha M Vasavada; Amber M Leaver; Stephanie Njau; Shantanu H Joshi; Linda Ercoli; Gerhard Hellemann; Katherine L Narr; Randall Espinoza
Journal:  J ECT       Date:  2017-12       Impact factor: 3.635

2.  Cognitive Remediation for Schizophrenia.

Authors:  Anthony O Ahmed
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

Review 3.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.

Authors:  Roumen V Milev; Peter Giacobbe; Sidney H Kennedy; Daniel M Blumberger; Zafiris J Daskalakis; Jonathan Downar; Mandana Modirrousta; Simon Patry; Fidel Vila-Rodriguez; Raymond W Lam; Glenda M MacQueen; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

4.  Is Conduct of Research in Electroconvulsive Therapy Ethical?

Authors:  N A Youssef; W V McCall
Journal:  J Psychol Neuropsychiatr Disord Brain Stimul       Date:  2016-05-13

Review 5.  The role of APOE-ɛ4 and beta amyloid in the differential rate of recovery from ECT: a review.

Authors:  T A Sutton; H R Sohrabi; S R Rainey-Smith; S M Bird; M Weinborn; R N Martins
Journal:  Transl Psychiatry       Date:  2015-03-31       Impact factor: 6.222

Review 6.  Recent Advances in Non-invasive Brain Stimulation for Major Depressive Disorder.

Authors:  Shui Liu; Jiyao Sheng; Bingjin Li; Xuewen Zhang
Journal:  Front Hum Neurosci       Date:  2017-11-06       Impact factor: 3.169

7.  Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial.

Authors:  Gordon Fernie; James Currie; Jennifer S Perrin; Caroline A Stewart; Virginica Anderson; Daniel M Bennett; Steven Hay; Ian C Reid
Journal:  Br J Psychiatry       Date:  2017-03-02       Impact factor: 9.319

8.  Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study.

Authors:  M Cano; I Martínez-Zalacaín; Á Bernabéu-Sanz; O Contreras-Rodríguez; R Hernández-Ribas; E Via; A de Arriba-Arnau; V Gálvez; M Urretavizcaya; J Pujol; J M Menchón; N Cardoner; C Soriano-Mas
Journal:  Transl Psychiatry       Date:  2017-02-07       Impact factor: 6.222

9.  Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.

Authors:  Lejla Sjanic Schmidt; Jeff Zarp Petersen; Maj Vinberg; Ida Hageman; Niels Vidiendal Olsen; Lars Vedel Kessing; Martin Balslev Jørgensen; Kamilla Woznica Miskowiak
Journal:  Trials       Date:  2018-04-19       Impact factor: 2.279

Review 10.  Brain Stimulation in Alzheimer's Disease.

Authors:  Chun-Hung Chang; Hsien-Yuan Lane; Chieh-Hsin Lin
Journal:  Front Psychiatry       Date:  2018-05-22       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.